| 臺大學術典藏 |
2021-01-28T01:06:38Z |
High-dose tamoxifen plus ifosfamide and anthracycline in a patient with angiosarcoma of the breast
|
Hsiao C.-H.;Kun-Huei Yeh;Chang Y.-C.;Tsai C.-C.; Hsiao C.-H.; KUN-HUEI YEH; Chang Y.-C.; Tsai C.-C. |
| 臺大學術典藏 |
1997 |
High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung
|
Yeh, K.-H. and Cheng, A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:07:00Z |
High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung
|
Kun-Huei Yeh;Cheng A.-L.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T02:02:39Z |
High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung
|
Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-01-06T03:59:02Z |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
|
Yeh K.-H.; Lin M.-T.; Lin D.-T.; JIH-LUH TANG; Lui L.-T.; Lin J.-F.; Chang Y.-S.; Cheng A.-L.; Yu S.-C.; Chang K.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:36Z |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
|
Yeh K.-H.; Lin M.-T.; Lin D.-T.; Tang J.-L.; Lui L.-T.; Lin J.-F.; Chang Y.-S.; ANN-LII CHENG; Yu S.-C.; Chang K.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-28T01:06:56Z |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
|
KUN-HUEI YEH; Lin M.-T.; Lin D.-T.; Tang J.-L.; Lui L.-T.; Lin J.-F.; Chang Y.-S.; Cheng A.-L.; Yu S.-C.; Chang K.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2021-05-26T09:08:24Z |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
|
Yeh K.-H.; Lin M.-T.; Lin D.-T.; Tang J.-L.; Lui L.-T.; Lin J.-F.; Chang Y.-S.; Cheng A.-L.; Yu S.-C.; Chang K.-J.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2022-08-12T06:29:03Z |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
|
Yeh K.-H.; Lin M.-T.; Lin D.-T.; Tang J.-L.; Lui L.-T.; Lin J.-F.; Chang Y.-S.; Cheng A.-L.; Yu S.-C.; KING-JEN CHANG; Chen Y.-C. |
| 國立臺灣大學 |
1998 |
High-Dose Therapy with Peripheral Blood Stem Cells (Pbscs) Support Using an Innovative Mobilization Regimen in Patients with High-Risk Primary or Chemoresponsive Metastatic Breast Cancers
|
葉坤輝; 林敏哲; 林東燦; 唐季祿; 雷德; 林靜芳; 張玉憲; 鄭安理; 張金堅; 陳耀昌; YEH, KUN-HUEI; LIN, MING-TSEH; LIN, DONG-TSAMN; TANG, JIH-LUH; LUI, LOUIS TAK; LIN, JING-FANG; CHANG, YU-SHIAHN; CHENG, ANN-LII; CHANG, KING-JEN; CHEN, YAO-CHANG |
| 臺北醫學大學 |
2007 |
High-dose vascular endothelial growth factor increases surfactant protein gene expressions in preterm rat lung
|
汪棱芳; Chen CM; Wang LF |
| 臺北醫學大學 |
2007-09 |
High-dose vascular endothelial growth factor increases surfactant protein gene expressions in preterm rat lung.
|
陳中明; Chen CM; Wang LF |
| 國立成功大學 |
2023-05 |
High-dose vitamin C-induced acute oxalate nephropathy in a renal transplant recipient: A case report and literature review
|
Shen;Zong-Yu;Chen;Ying-Ren;Wang;Ming-Cheng;Chang;Shen-Shin |
| 臺大學術典藏 |
2018-09-10T08:03:18Z |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
Wang, C.-H. and Ma, M.H.-M. and Chou, H.-C. and Yen, Z.-S. and Yang, C.-W. and Fang, C.-C. and Chen, S.-C.; MATTHEW HUEI-MING MA; CHIH-HUNG WANG; CHENG-CHUNG FANG; CHIH-WEI YANG; SHYR-CHYR CHEN; ZUI-SHEN YEN |
| 臺大學術典藏 |
2020-02-07T08:48:42Z |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
Chen S.-C.;Fang C.-C.;Yang C.-W.;Yen Z.-S.;Chou H.-C.;MATTHEW HUEI-MING MA;Wang C.-H.; Wang C.-H.; MATTHEW HUEI-MING MA; Chou H.-C.; Yen Z.-S.; Yang C.-W.; Fang C.-C.; Chen S.-C. |
| 臺大學術典藏 |
2020-03-12T06:54:26Z |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
Chen S.-C.; Fang C.-C.; Yen Z.-S.; CHIH-WEI YANG; Chou H.-C.; Ma M.H.-M.; Wang C.-H.; Wang C.-H.;Ma M.H.-M.;Chou H.-C.;Yen Z.-S.;Chih-Wei Yang;Fang C.-C.;Chen S.-C. |
| 臺大學術典藏 |
2020-03-19T04:29:11Z |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
Wang C.-H.;Ma M.H.-M.;Chou H.-C.;Zui-Shen Yen;Yang C.-W.;Fang C.-C.;Chen S.-C.; Wang C.-H.; Ma M.H.-M.; Chou H.-C.; ZUI-SHEN YEN; Yang C.-W.; Fang C.-C.; Chen S.-C. |
| 臺大學術典藏 |
2020-03-20T08:05:59Z |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
Chen S.-C.;Fang C.-C.;Yang C.-W.;Yen Z.-S.;Chou H.-C.;Ma M.H.-M.;CHIH-HUNG WANG; CHIH-HUNG WANG; Ma M.H.-M.; Chou H.-C.; Yen Z.-S.; Yang C.-W.; Fang C.-C.; Chen S.-C. |
| 臺大學術典藏 |
2020-03-24T07:38:02Z |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
Wang C.-H.; Ma M.H.-M.; Chou H.-C.; Yen Z.-S.; Yang C.-W.; CHENG-CHUNG FANG; Chen S.-C. |
| 臺大學術典藏 |
2010 |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
SHYR-CHYR CHEN; Fang C.-C.; Chou H.-C.; Yen Z.-S.; Yang C.-W.; Wang C.-H.; Ma M.H.-M.; SHYR-CHYR CHEN;Fang C.-C.;Yang C.-W.;Yen Z.-S.;Chou H.-C.;Ma M.H.-M.;Wang C.-H. |
| 臺大學術典藏 |
2020-12-07T07:11:51Z |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
Wang C.-H.; Ma M.H.-M.; Chou H.-C.; Yen Z.-S.; Yang C.-W.; Fang C.-C.; SHYR-CHYR CHEN |
| 臺大學術典藏 |
2020-12-16T07:56:48Z |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
Wang C.-H.;Ma M.H.-M.;Chou H.-C.;Yen Z.-S.;Yang C.-W.;Fang C.-C.;Shyr-Chyr Chen; Wang C.-H.; Ma M.H.-M.; Chou H.-C.; Yen Z.-S.; Yang C.-W.; Fang C.-C.; SHYR-CHYR CHEN |
| 臺大學術典藏 |
2010 |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
Chou H.-C.; MATTHEW HUEI-MING MA; Wang C.-H.; Yen Z.-S.; Yang C.-W.; Fang C.-C.; Chen S.-C. |
| 臺大學術典藏 |
2020-12-24T07:24:47Z |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
Chen S.-C.; Fang C.-C.; Yang C.-W.; Yen Z.-S.; MATTHEW HUEI-MING MA; Chou H.-C.; Wang C.-H.; Wang C.-H.;Matthew Huei-Ming Ma;Chou H.-C.;Yen Z.-S.;Yang C.-W.;Fang C.-C.;Chen S.-C. |
| 臺大學術典藏 |
2020-12-28T05:54:08Z |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
Chen S.-C.; Fang C.-C.; Yang C.-W.; Yen Z.-S.; Chou H.-C.; Ma M.H.-M.; CHIH-HUNG WANG |
